Turner White CommunicationsAbout TWCSubscribeContact TWCHomeSearch
Hospital PhysicianJCOMSMPBRMsCart
Current Contents
Past Issue Archives
Interactive:
Self-Assessment Questions
Review of
Clinical Signs
Clinical Review
Quiz
Pediatric Rounds
Resident Grand Rounds
Article Archives
Case Reports
Clinical Practice
Exams
Pediatric Rounds
Resident Grand Rounds
Review of
Clinical Signs

Guide to Reading
Hospital Physician
Editorial Board
Information for Authors

Reprints, Permissions, & Copyright
Site Map
Self-Assessment Questions


Urology


Answer 1
  1. Explain that this is a common side effect but ejaculatory volume will not likely change with continued therapy. α-Adrenergic antagonists are predominantly used in the treatment of benign prostatic hyperplasia. Tamsulosin, a selective α1A-adrenoreceptor antagonist, is associated with retrograde ejaculation in approximately 5% to 10% of patients. This side effect is reversible when therapy is stopped. Although this is a benign condition, the effect is not self-limited and ejaculatory volume will remain low throughout treatment. Patients should be counseled about potential side effects before initiating treatment. There is some evidence that intermittent (once every other day) dosing may improve retrograde ejaculation in patients who report no change in their ejaculatory volume.¹ This improvement, however, was not found in patients with low volume or absent ejaculate.

    REFERENCES
    1. Goktas S, Kibar Y, Kilic S, et al. Recovery of abnormal ejaculation by intermittent tamsulosin treatment. J Urol 2006;175:6503.

Click here to return to the questions

 

Hospital Physician     JCOM     Seminars in Medical Practice
Hospital Physician Board Review Manuals
About TWC    Subscribe    Contact TWC    Home    Search   Site Map

Copyright © 2009, Turner White Communications
Updated 2/25/08 • nvf